In addition, the research of Luo et al. unveiled the downregulation of Reprimo in gastric adenocarcinoma tissues, and that the loss of Reprimo was correlated to promoted tumor invasion, lymphatic vessel invasion, and lymph node metastasis in gastric adenocarcinoma [43]. Here, RPRM is linked to gastric adenocarcinoma.